TG THERAPEUTICS, INC. Restricted Cash and Cash Equivalents, Noncurrent
TG THERAPEUTICS, INC. (TGTX) had Restricted Cash and Cash Equivalents, Noncurrent of $1.25 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-11-12
- 2019-09-30: Restricted Cash and Cash Equivalents, Noncurrent $1.25M.
- 2019-06-30: Restricted Cash and Cash Equivalents, Noncurrent $1.25M.
- 2019-03-31: Restricted Cash and Cash Equivalents, Noncurrent $1.24M.
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $1.24M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2019-09-30 | $1.25M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.25M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.24M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.24M 10-Q · filed 2019-11-12 | |
| 2018-09-30 | $1.24M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.24M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $588.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $587.00K 10-K · filed 2019-03-01 | $587.29K 10-K · filed 2018-03-15 |
| 2017-09-30 | $586.26K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $585.23K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $584.21K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $583.21K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $582.18K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $581.16K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $580.15K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $579.14K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $578.13K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $577.11K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $576.07K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $575.01K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |